{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T11:10:06Z","timestamp":1794568206486,"version":"4.9.1"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["DA037820"],"award-info":[{"award-number":["DA037820"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Drug Policy"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.drugpo.2019.01.010","type":"journal-article","created":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T23:33:34Z","timestamp":1549064014000},"page":"183-188","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":638,"special_numbering":"C","title":["The triple wave epidemic: Supply and demand drivers of the US opioid overdose crisis"],"prefix":"10.1016","volume":"71","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2355-5477","authenticated-orcid":false,"given":"Daniel","family":"Ciccarone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugpo.2019.01.010_bib0005","series-title":"Letter to Congress: Response to questions concerning fentanyl","author":"Baum","year":"2017"},{"key":"10.1016\/j.drugpo.2019.01.010_bib0010","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.drugpo.2017.05.050","article-title":"Today\u2019s fentanyl crisis: Prohibition\u2019s Iron Law, revisited","volume":"46","author":"Beletsky","year":"2017","journal-title":"The International Journal of Drug Policy"},{"key":"10.1016\/j.drugpo.2019.01.010_bib0015","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.drugpo.2017.12.003","article-title":"Multiple injections per injection episode: High-risk injection practice among people who injected pills during the 2015 HIV outbreak in Indiana","volume":"52","author":"Broz","year":"2018","journal-title":"The International Journal of Drug Policy"},{"key":"10.1016\/j.drugpo.2019.01.010_bib0020","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.drugpo.2017.05.023","article-title":"Exposure to fentanyl-contaminated heroin and overdose risk among illicit opioid users in Rhode Island: A mixed methods study","volume":"46","author":"Carroll","year":"2017","journal-title":"The International Journal of Drug Policy"},{"key":"10.1016\/j.drugpo.2019.01.010_bib0025","series-title":"How goes the \u201cwar on drugs\u201d? An assessment of U.S. drug problems and policy","author":"Caulkins","year":"2005"},{"key":"10.1016\/j.drugpo.2019.01.010_bib0030","series-title":"2016 National Survey on Drug Use and Health: Detailed Tables","author":"Center for Behavioral Health Statistics and Quality","year":"2017"},{"key":"10.1016\/j.drugpo.2019.01.010_bib0035","first-page":"1487","article-title":"Vital signs: Overdoses of prescription opioid pain relievers --- United States, 1999--2008","volume":"60","author":"Centers for Disease Control and Prevention","year":"2011","journal-title":"Morbidity and Mortality Weekly Report (MMWR)"},{"issue":"3","key":"10.1016\/j.drugpo.2019.01.010_bib0040","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.drugpo.2008.08.003","article-title":"Heroin in brown, black and white: Structural factors and medical consequences in the US heroin market","volume":"20","author":"Ciccarone","year":"2009","journal-title":"The International Journal of Drug Policy"},{"key":"10.1016\/j.drugpo.2019.01.010_bib0045","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.drugpo.2017.06.010","article-title":"Fentanyl in the US heroin supply: A rapidly changing risk environment","volume":"46","author":"Ciccarone","year":"2017","journal-title":"The International Journal of Drug Policy"},{"key":"10.1016\/j.drugpo.2019.01.010_bib0050","doi-asserted-by":"crossref","DOI":"10.1001\/jamaneurol.2019.0183","article-title":"Heroin smoking is not common in the United States","author":"Ciccarone","year":"2019","journal-title":"JAMA Neurology"},{"issue":"5","key":"10.1016\/j.drugpo.2019.01.010_bib0055","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.drugpo.2008.12.001","article-title":"Impact of South American heroin on the US heroin market 1993\u20132004","volume":"20","author":"Ciccarone","year":"2009","journal-title":"The International Journal of Drug Policy"},{"key":"10.1016\/j.drugpo.2019.01.010_bib0060","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.drugpo.2017.06.004","article-title":"Heroin uncertainties: Exploring users\u2019 perceptions of fentanyl-adulterated and -substituted \u2018heroin\u2019","volume":"46","author":"Ciccarone","year":"2017","journal-title":"The International Journal of Drug Policy"},{"issue":"2","key":"10.1016\/j.drugpo.2019.01.010_bib0065","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1056\/NEJMc1204141","article-title":"Effect of abuse-deterrent formulation of OxyContin","volume":"367","author":"Cicero","year":"2012","journal-title":"The New England Journal of Medicine"},{"issue":"7","key":"10.1016\/j.drugpo.2019.01.010_bib0070","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1001\/jamapsychiatry.2014.366","article-title":"The changing face of heroin use in the United States: A retrospective analysis of the past 50 years","volume":"71","author":"Cicero","year":"2014","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.drugpo.2019.01.010_bib0075","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.addbeh.2018.05.030","article-title":"Increased use of heroin as an initiating opioid of abuse: Further considerations and policy implications","volume":"87","author":"Cicero","year":"2018","journal-title":"Addictive Behaviors"},{"key":"10.1016\/j.drugpo.2019.01.010_bib0080","series-title":"Forces of habit. Drugs and the making of the modern world","author":"Courtwright","year":"2001"},{"key":"10.1016\/j.drugpo.2019.01.010_bib0085","series-title":"Dark paradise: A history of opiate addiction in America","author":"Courtwright","year":"2001"},{"issue":"2","key":"10.1016\/j.drugpo.2019.01.010_bib0090","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0376-8716(98)00159-8","article-title":"Fluctuations in heroin purity and the incidence of fatal heroin overdose","volume":"54","author":"Darke","year":"1999","journal-title":"Drug and Alcohol Dependence"},{"issue":"2","key":"10.1016\/j.drugpo.2019.01.010_bib0095","doi-asserted-by":"crossref","first-page":"182","DOI":"10.2105\/AJPH.2017.304187","article-title":"Opioid crisis: No easy fix to its social and economic determinants","volume":"108","author":"Dasgupta","year":"2018","journal-title":"American Journal of Public Health"},{"issue":"3","key":"10.1016\/j.drugpo.2019.01.010_bib0100","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1080\/713659379","article-title":"Drug consumption facilities in Europe and the establishment of supervised injecting centres in Australia","volume":"19","author":"Dolan","year":"2000","journal-title":"Drug and Alcohol Review"},{"key":"10.1016\/j.drugpo.2019.01.010_bib0105","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.drugpo.2017.06.005","article-title":"Naloxone for heroin, prescription opioid, and illicitly made fentanyl overdoses: Challenges and innovations responding to a dynamic epidemic","volume":"46","author":"Fairbairn","year":"2017","journal-title":"The International Journal of Drug Policy"},{"issue":"33","key":"10.1016\/j.drugpo.2019.01.010_bib0110","doi-asserted-by":"crossref","first-page":"837","DOI":"10.15585\/mmwr.mm6533a2","article-title":"Fentanyl law enforcement submissions and increases in synthetic opioid-involved overdose deaths - 27 states, 2013\u20132014","volume":"65","author":"Gladden","year":"2016","journal-title":"MMWR Morbidity and Mortality Weekly Report"},{"key":"10.1016\/j.drugpo.2019.01.010_bib0115","series-title":"Drug overdose deaths in the United States, 1999-2017. NCHS Data Brief, no 329","author":"Hedegaard","year":"2018"},{"issue":"6408","key":"10.1016\/j.drugpo.2019.01.010_bib0120","doi-asserted-by":"crossref","DOI":"10.1126\/science.aau1184","article-title":"Changing dynamics of the drug overdose epidemic in the United States from 1979 through 2016","volume":"361","author":"Jalal","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.drugpo.2019.01.010_bib0125","series-title":"Drug deaths in America are rising faster than ever","author":"Katz","year":"2017"},{"key":"10.1016\/j.drugpo.2019.01.010_bib0130","series-title":"How a police chief, a governor and a sociologist would spend $100 billion to solve the opioid crisis","author":"Katz","year":"2018"},{"issue":"1","key":"10.1016\/j.drugpo.2019.01.010_bib0135","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.drugpo.2006.12.008","article-title":"A micro-environmental intervention to reduce the harms associated with drug-related overdose: Evidence from the evaluation of Vancouver\u2019s safer injection facility","volume":"18","author":"Kerr","year":"2007","journal-title":"The International Journal of Drug Policy"},{"key":"10.1016\/j.drugpo.2019.01.010_bib0140","series-title":"What America's Users Spend on Illegal Drugs: 2000\u20132010","author":"Kilmer","year":"2014"},{"key":"10.1016\/j.drugpo.2019.01.010_bib0145","series-title":"Statement before the subcommittee on Africa, global health","author":"Knierim","year":"2018"},{"key":"10.1016\/j.drugpo.2019.01.010_bib0150","series-title":"Mortality in the United States, 2016. NCHS Data Brief, no 293","author":"Kochanek","year":"2017"},{"key":"10.1016\/j.drugpo.2019.01.010_bib0155","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1146\/annurev-publhealth-031914-122957","article-title":"The prescription opioid and heroin crisis: A public health approach to an epidemic of addiction","volume":"36","author":"Kolodny","year":"2015","journal-title":"Annual Review of Public Health"},{"issue":"5","key":"10.1016\/j.drugpo.2019.01.010_bib0160","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1001\/jamapsychiatry.2017.0163","article-title":"The surge of opioid use, addiction, and overdoses: Responsibility and response of the US health care system","volume":"74","author":"Madras","year":"2017","journal-title":"JAMA Psychiatry"},{"issue":"2","key":"10.1016\/j.drugpo.2019.01.010_bib0165","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.drugpo.2013.10.004","article-title":"Every\u2019 never\u2019 I ever said came true\": Transitions from opioid pills to heroin injecting","volume":"25","author":"Mars","year":"2014","journal-title":"The International Journal of Drug Policy"},{"issue":"2","key":"10.1016\/j.drugpo.2019.01.010_bib0170","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1080\/02791072.2017.1394508","article-title":"Sold as Heroin: Perceptions and Use of an Evolving Drug in Baltimore, MD","volume":"50","author":"Mars","year":"2018","journal-title":"Journal of Psychoactive Drugs"},{"key":"10.1016\/j.drugpo.2019.01.010_bib0175","article-title":"Illicit fentanyls in the opioid street market: Desired or imposed?","author":"Mars","year":"2018","journal-title":"Addiction"},{"issue":"9775","key":"10.1016\/j.drugpo.2019.01.010_bib0180","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/S0140-6736(10)62353-7","article-title":"Reduction in overdose mortality after the opening of North America\u2019s first medically supervised safer injecting facility: A retrospective population-based study","volume":"377","author":"Marshall","year":"2011","journal-title":"The Lancet"},{"key":"10.1016\/j.drugpo.2019.01.010_bib0185","series-title":"CIA complicity in the global drug trade","article-title":"The politics of heroin","author":"McCoy","year":"2003"},{"key":"10.1016\/j.drugpo.2019.01.010_bib0190","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.drugpo.2018.04.017","article-title":"Fentanyl self-testing outside supervised injection settings to prevent opioid overdose: Do we know enough to promote it?","volume":"58","author":"McGowan","year":"2018","journal-title":"The International Journal of Drug Policy"},{"key":"10.1016\/j.drugpo.2019.01.010_bib0195","series-title":"Mortality in the United States, 2017. NCHS Data Brief, no 328","author":"Murphy","year":"2018"},{"key":"10.1016\/j.drugpo.2019.01.010_bib0200","series-title":"The American disease: Origins of narcotic control","author":"Musto","year":"1999"},{"key":"10.1016\/j.drugpo.2019.01.010_bib0205","series-title":"Overdose death rates","author":"National Institute on Drug Abuse","year":"2018"},{"issue":"2","key":"10.1016\/j.drugpo.2019.01.010_bib0210","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1002\/pam.22049","article-title":"A supply-side perspective on the opioid crisis","volume":"37","author":"Pacula","year":"2018","journal-title":"Journal of Policy Analysis and Management"},{"key":"10.1016\/j.drugpo.2019.01.010_bib0215","series-title":"CT-497. Testimony presented before the house foreign affairs subcommittee on Africa, global health, global human rights, and international organizations on tackling fentanyl: The China connection on September 6, 2018","article-title":"Evolution of the US overdose crisis: Understanding China\u2019s role in the production and supply of synthetic opioids","author":"Pardo","year":"2018"},{"key":"10.1016\/j.drugpo.2019.01.010_bib0220","article-title":"Fentanyl test strips as an opioid overdose prevention strategy: Findings from a syringe services program in the Southeastern United States","author":"Peiper","year":"2018","journal-title":"The International Journal of Drug Policy"},{"issue":"3","key":"10.1016\/j.drugpo.2019.01.010_bib0225","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJMoa1515195","article-title":"HIV infection linked to injection use of Oxymorphone in Indiana, 2014\u20132015","volume":"375","author":"Peters","year":"2016","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.drugpo.2019.01.010_bib0230","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.drugalcdep.2014.10.012","article-title":"Supervised injection services: What has been demonstrated? A systematic literature review","volume":"145","author":"Potier","year":"2014","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.drugpo.2019.01.010_bib0235","series-title":"White House commission recommends president declare a national emergency over the deadly opioid epidemic","author":"Simmons","year":"2017"},{"key":"10.1016\/j.drugpo.2019.01.010_bib0240","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.drugalcdep.2016.11.033","article-title":"A review: Fentanyl and non-pharmaceutical fentanyls","volume":"171","author":"Suzuki","year":"2017","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.drugpo.2019.01.010_bib0245","series-title":"Mortality trends in the United States, 1900\u20132015","author":"Tejada Vera","year":"2017"},{"key":"10.1016\/j.drugpo.2019.01.010_bib0250","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.drugpo.2017.06.003","article-title":"US regional and demographic differences in prescription opioid and heroin-related overdose hospitalizations","volume":"46","author":"Unick","year":"2017","journal-title":"The International Journal of Drug Policy"},{"issue":"2","key":"10.1016\/j.drugpo.2019.01.010_bib0255","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0054496","article-title":"Intertwined epidemics: National demographic trends in hospitalizations for heroin- and opioid-related overdoses, 1993\u20132009","volume":"8","author":"Unick","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.drugpo.2019.01.010_bib0260","series-title":"Undetermined risk factors and mode of transmission for HIV infection among persons who inject drugs \u2014 Massachusetts, 2018","author":"US Centers for Disease Control and Prevention","year":"2018"},{"key":"10.1016\/j.drugpo.2019.01.010_bib0265","series-title":"2015 National Drug Threat Assessment Summary","author":"US Drug Enforcement and Administration","year":"2015"},{"key":"10.1016\/j.drugpo.2019.01.010_bib0270","series-title":"2016 National Drug Threat Assessment Summary","author":"US Drug Enforcement and Administration","year":"2016"},{"key":"10.1016\/j.drugpo.2019.01.010_bib0275","series-title":"Colombian cocaine production expansion contributes to rise in supply in the United States. (DEA intelligence brief, DEA-DCI-DIB-014-17)","author":"US Drug Enforcement Administration","year":"2017"},{"key":"10.1016\/j.drugpo.2019.01.010_bib0280","series-title":"National drug threat assessment. (DEA-DCT-DIR-040-17)","author":"US Drug Enforcement Administration","year":"2017"},{"key":"10.1016\/j.drugpo.2019.01.010_bib0285","series-title":"Surgeon general\u2019s advisory on naloxone and opioid overdose","author":"US Surgeon General","year":"2018"},{"issue":"2","key":"10.1016\/j.drugpo.2019.01.010_bib0290","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2105\/AJPH.2007.131714","article-title":"The promotion and marketing of oxycontin: Commercial triumph, public health tragedy","volume":"99","author":"Van Zee","year":"2009","journal-title":"American Journal of Public Health"},{"issue":"22","key":"10.1016\/j.drugpo.2019.01.010_bib0295","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1056\/NEJMp1402780","article-title":"Medication-assisted therapies \u2013 Tackling the opioid-overdose epidemic","volume":"370","author":"Volkow","year":"2014","journal-title":"The New England Journal of Medicine"},{"issue":"23","key":"10.1016\/j.drugpo.2019.01.010_bib0300","first-page":"631","article-title":"Opioid overdose prevention programs providing naloxone to laypersons-United States, 2014","volume":"64","author":"Wheeler","year":"2015","journal-title":"MMWR Morbidity and Mortality Weekly Report"},{"key":"10.1016\/j.drugpo.2019.01.010_bib0305","series-title":"Mortality in the United States, 2015. NCHS data brief, no 267","author":"Xu","year":"2016"}],"container-title":["International Journal of Drug Policy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955395919300180?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955395919300180?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T15:45:04Z","timestamp":1760629504000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0955395919300180"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":61,"alternative-id":["S0955395919300180"],"URL":"https:\/\/doi.org\/10.1016\/j.drugpo.2019.01.010","relation":{},"ISSN":["0955-3959"],"issn-type":[{"value":"0955-3959","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The triple wave epidemic: Supply and demand drivers of the US opioid overdose crisis","name":"articletitle","label":"Article Title"},{"value":"International Journal of Drug Policy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugpo.2019.01.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Author. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}